Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
A ModestoM Rives

Abstract

The optimal dose in esophageal cancer patients treated with definitive chemoradiation (CRT) remains debated. We herein report on the dosimetric results, treatment-related toxicities and long-term outcomes of escalated dose up to 60Gy delivered with intensity-modulated radiotherapy (IMRT). All consecutive patients that received a definitive CRT>50Gy for an unresectable esophageal carcinoma between 2010 and 2015 were retrospectively evaluated for this study. Methodology included data base search, delayed toxicity grading, statistical testing including frequency analysis and survival analysis. A total of 51 patients were irradiated for a squamous cell carcinoma (86.3%) or an adenocarcinoma (13.7%). The median age at diagnosis was 62 years. Seven patients were simultaneously irradiated for another synchronous primary tumor. Forty-six patients (90.2%) received concurrent platin-based chemotherapy. The median prescribed doses were 60Gy (54-66) and 48Gy (44.8-56) delivered in 30 (27-35) fractions to the high and the low risks PTV respectively. The mean dose delivered to the lungs was 11.4Gy (IC 95%: 4.8-19.8), the median volumes receiving up to 20Gy (V20) and 30Gy (V30) were 13.5% (3.0-46.0) and 4.6% (0.7-19.8) respectively. The mean ...Continue Reading

References

Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D MinskyDavid P Kelsen
Dec 7, 2006·American Journal of Clinical Oncology·Gilles CréhangeJean François Bosset
Mar 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joel TepperRobert Mayer
Aug 12, 2009·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·M HurmuzluA Viste
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V GrégoireUNKNOWN EHNS-ESMO-ESTRO Guidelines Working Group
Dec 3, 2010·International Journal of Radiation Oncology, Biology, Physics·James WelshRitsuko Komaki
Jun 21, 2011·The Lancet Oncology·Katrin M SjoquistUNKNOWN Australasian Gastro-Intestinal Trials Group
Feb 22, 2014·The Lancet Oncology·Thierry ConroyUNKNOWN Fédération Francophone de Cancérologie Digestive and UNICANCER-GI Group
Nov 5, 2014·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Anouchka ModestoMichel Rives
Apr 11, 2015·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Laure VieillevigneMichel Rives
Apr 22, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W E E EberhardtUNKNOWN Panel Members
Aug 1, 2015·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Coraline BednarekStéphanie Servagi Vernat
Feb 5, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gérard LledoAimery de Gramont
Jul 13, 2019·International Journal of Radiation Oncology, Biology, Physics·Jihane BoustaniFlorence Huguet
Sep 8, 2019·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·V BourbonnéS Servagi-Vernat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.